HOME >> MEDICINE >> NEWS
Aspirin might prevent development of oesophageal adenocarcinoma

Non-steroidal anti-inflammatory drugs (NSAID) such as aspirin might be effective in preventing the development of oesophageal adenocarcinoma in patients with Barrett's oesophagus, according to US researchers reporting online in THE LANCET ONCOLOGY. "An inexpensive, widely available, and fairly safe means of preventing neoplastic progression in people at high risk of oesophageal cancer would have substantial benefits in terms of public health and economics", says lead author Dr Thomas Vaughan.

Barrett's oesophagus is a metaplastic disorder that develops in about 10% of people with chronic gastro-oesophageal reflux disease. Every year about 0.5%-1% of patients with Barrett's oesophagus develop oesophageal adenocarcinoma. Although the incidence of oesophageal adenocarcinoma is increasing, the mechanisms underlying its development are not yet fully understood. NSAID use is thought to prevent the development of colorectal cancer and adenomatous polyps mainly through inhibition of cyclo-oxygenase, an enzyme with tumour-promoting properties. Human and animal studies have suggested these drugs might have a role in preventing neoplastic progression in oesophageal adenocarcinoma.

Vaughan and colleagues therefore investigated prospectively the relation between the duration, frequency, and recency of NSAID use and risk of oesophageal adenocarcinoma in 350 people with Barrett's oesophagus. Median follow-up was 65.5 months (range 3.1-106.9).

Current NSAID users had a significantly lower risk than never users (Hazard ratio [HR] 0.32 [95% CI 0.14-0.76]). Former users also had a lower risk but this was non-significant. No relation with risk for duration and frequency of drug use was found. The associations were strengthened when NSAID use during follow up was taken into account (HR 0.20 [0.10-0.41]) for current users compared never users. 5-year cumulative incidence of oesophageal adenocarcinoma was 14.3% (9.3-21.6) for never users, 9.7% (4.5-20.5) for forme
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
7-Nov-2005


Page: 1 2

Related medicine news :

1. Aspirin use during pregnancy could reduce risk of pre-eclampsia
2. Aspirin reduces esophageal-cancer risk in people with most-aggressive form of Barretts esophagus
3. Aspirin saves lives of cancer patients suffering heart attacks, despite fears of bleeding
4. Aspirin and other NSAIDs may not reduce the risk of colorectal cancer in long-term smokers
5. Aspirin + dipyridamole better than aspirin alone to prevent circulatory problems after minor stroke
6. Aspirin shows promise in combating a common, antibiotic-induced hearing loss
7. Aspirin to prevent heart disease is beneficial in a wider range of men
8. Aspirin therapy may be safe for some survivors of brain hemorrhage
9. Aspirin reduces the risk of cardiovascular events, though effects differ between men and women
10. Aspirin reduces cardiovascular risks in men and women -- but differently
11. Aspirin may help the heart, but one in ten patients will also develop an ulcer, new research shows

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... ... for healthcare compliance program management, will showcase a range of technology and learning ... Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 at ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the Los ... article to the newly revamped Cosmetic Town journal section, featuring articles ... procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi says ...
(Date:10/12/2017)... Mich. (PRWEB) , ... October 12, 2017 , ... ... has been named one of Michigan’s 2017 Best and Brightest in Wellness® by ... Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... Dining at the University of California Berkeley, and other leading institutions in announcing ... buying power of institutions to change the way animals are raised for food. ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... , Pa. and KALAMAZOO, Mich. , Sept. ... Penn. , and OptiMed Specialty Pharmacy of ... partnership to offer a strategic hub service that expedites ... highly sought-after personal spirometer, Spiro PD 2.0, and wellness ... A spirometer is a medical device used to measure ...
(Date:9/12/2017)... PARIS and NEW YORK , Sept. 12, ... ethical performance ratings for global supply chains, has published the first annual ... the CSR performance of more than 20,400 companies evaluated by EcoVadis, based ... years 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
(Date:9/9/2017)... -- ... Washington DC ... 12 th – Monday, September 18 th .The Brain Tumor Foundation ... scans to the public.Where:  BTF,s Mobile MRI Unit ... Street NW, Washington, D.C.What:BTF brings its nationwide initiative, the Road to Early ...
Breaking Medicine Technology:
Cached News: